Evidence synthesis, parameter correlation and probabilistic sensitivity analysis

被引:56
作者
Ades, AE
Claxton, K
Sculpher, M
机构
[1] MRC Hlth Sci Collaborat, Bristol BS6 6RT, Avon, England
[2] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England
基金
英国医学研究理事会;
关键词
cost-effectiveness analysis; sensitivity analysis; correlation; evidence synthesis; Bayesian MCMC;
D O I
10.1002/hec.1068
中图分类号
F [经济];
学科分类号
02 ;
摘要
Over the last decade or so, there have been many developments in methods to handle uncertainty in cost-effectiveness studies. In decision modelling, it is widely accepted that there needs to be an assessment of how sensitive the decision is to uncertainty in parameter values. The rationale for probabilistic sensitivity analysis (PSA) is primarily based on a consideration of the needs of decision makers in assessing the consequences of decision uncertainty. In this paper, we highlight some further compelling reasons for adopting probabilistic methods for decision modelling and sensitivity analysis, and specifically for adopting simulation from a Bayesian posterior distribution. Our reasoning is as follows. Firstly, cost-effectiveness analyses need to be based on all the available evidence, not a selected subset, and the uncertainties in the data need to be propagated through the model in order to provide a correct analysis of the uncertainties in the decision. In many - perhaps most - cases the evidence structure requires a statistical analysis that inevitably induces correlations between parameters. Deterministic sensitivity analysis requires that models are run with parameters fixed at 'extreme' values, but where parameter correlation exists it is not possible to identify sets of parameter values that can be considered 'extreme' in a meaningful sense. However, a correct probabilistic analysis can be readily achieved by Monte Carlo sampling from the joint posterior distribution of parameters. In this paper, we review some evidence structures commonly occurring in decision models, where analyses that correctly reflect the uncertainty in the data induce correlations between parameters. Frequently, this is because the evidence base includes information on functions of several parameters. It follows that, if health technology assessments are to be based on a correct analysis of all available data, then probabilistic methods must be used both for sensitivity analysis and for estimation of expected costs and benefits. Copyright (c) 2005 John Wiley & Sons, Ltd.
引用
收藏
页码:373 / 381
页数:9
相关论文
共 77 条
[11]  
Bedford T., 2001, Mathematical tools for probabilistic risk analysis
[12]   Updating uncertainty in an integrated risk assessment: Conceptual framework and methods [J].
Brand, KP ;
Small, MJ .
RISK ANALYSIS, 1995, 15 (06) :719-731
[13]  
BRIDLE C, 2004, HLTH TECHNOL ASSESS, V8
[14]   An introduction to Markov modelling for economic evaluation [J].
Briggs, A ;
Sculpher, M .
PHARMACOECONOMICS, 1998, 13 (04) :397-409
[15]  
Briggs AH, 1999, HEALTH ECON, V8, P257, DOI 10.1002/(SICI)1099-1050(199905)8:3<257::AID-HEC427>3.0.CO
[16]  
2-E
[17]   Probabilistic sensitivity analysis for decision trees with multiple branches: Use of the Dirichlet distribution in a Bayesian framework [J].
Briggs, AH ;
Ades, AE ;
Price, MJ .
MEDICAL DECISION MAKING, 2003, 23 (04) :341-350
[18]  
Campolongo Francesca., 2000, Sensitivity analysis, P15
[19]   Correlations in uncertainty analysis for medical decision making: An application to heart-valve replacement [J].
Chessa, AG ;
Dekker, R ;
van Vliet, B ;
Steyerberg, EW ;
Habbema, JDF .
MEDICAL DECISION MAKING, 1999, 19 (03) :276-286
[20]  
Claxton K, 1996, HEALTH ECON, V5, P513, DOI 10.1002/(SICI)1099-1050(199611)5:6<513::AID-HEC237>3.0.CO